Novel Therapeutics for Rare Lymphomas.

By:

Christopher Dittus

Material type: Text

TextLanguage: English Publication details: Department of Medicine, Division of Hematology and Oncology University of North Carolina at Chapel Hill Chapel Hill, NC USA | Springer Nature Switzerland AG | 2020Description: 259 Pages; Includes ReferencesISBN:

978-3-030-25609-8
978-3-030-25610-4 (eBook)

Subject(s):

-- Hematology, Medical / Clinical Medicine, Medical / Hematology, Medical / Oncology / General, Oncology, Lymphomas -- Treatment

Online resources:

Click here to access online

Summary: This comprehensive volume reviews the clinical presentation, diagnosis, and treatment approach to rare lymphomas. There is particular emphasis placed on new diagnostic approaches, novel chemotherapy combinations, and treatment modalities with novel therapeutics. It highlights research advances in a group of diseases that are often overlooked, and serves as a single repository of information on the most recent advances in targeted small molecule inhibitors, monoclonal antibodies, immunotherapy, and CAR-T therapy as they pertain to rare types of lymphoma. Written for practicing oncologists, hematologists, fellows, and residents, Novel Therapeutics for Rare Lymphomas covers rare subtypes of lymphoma, including indolent and aggressive T-cell lymphomas and B-cell lymphomas.

Item type: E-BOOKS

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

Holdings
Item type	Current library	URL	Copy number	Status	Barcode
E-BOOKS	MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO	Link to resource	20241031165052.0	Not for loan	20241031165052.0

Total holds: 0

This comprehensive volume reviews the clinical presentation, diagnosis, and treatment approach to rare lymphomas. There is particular emphasis placed on new diagnostic approaches, novel chemotherapy combinations, and treatment modalities with novel therapeutics. It highlights research advances in a group of diseases that are often overlooked, and serves as a single repository of information on the most recent advances in targeted small molecule inhibitors, monoclonal antibodies, immunotherapy, and CAR-T therapy as they pertain to rare types of lymphoma. Written for practicing oncologists, hematologists, fellows, and residents, Novel Therapeutics for Rare Lymphomas covers rare subtypes of lymphoma, including indolent and aggressive T-cell lymphomas and B-cell lymphomas.

There are no comments on this title.

to post a comment.